k-haler is a new asthma inhaler that has been designed to make patient use simple and easy. It is a breath activated device that requires lower inhalation force to trigger than most other similar inhalers. This also eliminates the need for asthma patients to coordinate their breathing and button pushing. Although designed for asthmatics, the technology within the k-haler is potentially suitable for a range of inhaled products. Its modern, user friendly, compact and simple design, combined with clever engineering, means k-haler is a truly world class device.
The Mundipharma global network of privately-owned independent associated companies was founded in 1956 by doctors and now operates in over 120 countries worldwide. We are focused on developing business partnerships to identify and accelerate meaningful technology across an increasingly diverse portfolio of therapy areas including respiratory, oncology, pain, and biosimilars. Consistent with our entrepreneurial heritage, we like to think we see what others don’t by challenging conventional wisdom and asking different and challenging questions. By working in partnership with all our stakeholders, the Mundipharma network develops medicines that create value for patients, payers and wider healthcare systems.
Results will be Announced to Public on April 15, 2025. Visit our winners' page on April 15, 2025 to see the worlds' leading designs, ideas, trends and concepts in 2025.
Registration to A' Design Award & Competition 2024-2025 period is now open. Register and upload your design today to know how good your design is: get a complimentary preliminary score.